IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Immunity of the Nasal Mucosa in Premature Infants of the First Year of Life

Author: ALBINA KALIMULLINA, VICTORIA AMIROVA, LILIYA AZNABAEVA, SVETLANA LARIONOVA, NATALIA SHAFAZHINSKAYA, NIKITA LOGACHEV, NIKOLAI MAKSIMYUK
Abstract: The indices of immunity on the nasal mucosa were studied in 47 children of the first year of life born prematurely at the gestational age of 28-37 weeks. ELISA test was used to determine antibodies (IgA, IgG, IgE) and cytokines (TNF-a, IL-1ß, IF-?) of nasal mucosa washes. The study found that premature infants had transient deficiency of IgG at the age of 6 months (2.08 (0.78-6.99) mg/ml) and low IgE indices at the age of 12 months (0.89 (0.47-of 1.32) ng/ml) against hyperproduction of IL-1ß and low idices of IF-? at the age of 6 months (7.51 (4.84-13.82) pg/ml) and 12 months (8.28 (4.70-12.07) pg/ml). Infants born at the gestational age of 28-32 weeks had the worst antibody and antiviral protection. The findings may be useful in the development of measures for the prevention and treatment of inflammatory respiratory infections in premature infants.
Keyword: immunity of the nasal mucosa, nasal cavity, premature infants
DOI: https://doi.org/10.31838/ijpr/2019.11.04.115
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus